Paramount Won't Sell Cable Networks After WBD Merger, Touts “Incredible Footprint” Of Combined Linear Business
Deadline· 2026-03-02 18:10
Paramount executives stressed today that once merged with Warner Bros. Discovery, the company combined has no plans to unload any legacy cable networks. CEO David Ellison and COO and Chief Strategy Officer Andy Gordon were asked about that several times by analysts on a call. They have spoken frequently already about the logic of retaining cable after Ellison’s Skydance acquired Paramount in August. “We believe in the assets we’re buying, and there’s no plans to divest or spin off a package of cable asse ...
Oil prices leap on worries about Iran war, while U.S. stocks trim their sharp losses
Investment Executive· 2026-03-02 18:09
The S&P 500 fell as much as 1.2% at the start of trading, and cruise lines and airlines led the way lower. But the index quickly erased the loss, in part because past military conflicts have not led to sustained drops for markets, and it was back to virtually unchanged in midday trading.The Dow Jones Industrial Average was down 58 points, or 0.1%, as of 12:37 p.m. Eastern time, and the Nasdaq composite was 0.4% higher.Prices for natural gas remained higher, meanwhile, which could raise heating bills for the ...
Martin Midstream Partners Announces 2025 K-1 Tax Package Availability
Businesswire· 2026-03-02 18:07
KILGORE, Texas--(BUSINESS WIRE)--Martin Midstream Partners L.P. (NASDAQ: MMLP) today announced that the Partnership's 2025 tax package, which includes Schedule K-1, is now available to download from the Investor Relations section of the Partnership's website and may also be accessed by visiting https://www.taxpackagesupport.com/martinmidstream. The Partnership will begin mailing the 2025 tax package to its unitholders on Thursday, March 5, 2026. For additional information, unitholders may conta. ...
Should Investors Buy CSX Stock Post Its Latest Dividend Hike?
ZACKS· 2026-03-02 18:06
Key Takeaways CSX raised its quarterly dividend to 14 cents per share from 13 cents.CSX has been consistently making efforts to reward its shareholders through dividends and share buybacks.During 2025, CSX repurchased shares worth $1.39 billion and paid $972 million in dividends.Last week, CSX Corporation (CSX) ) stated that its board of directors had announced an increase in its quarterly dividend payout, reflecting the company’s commitment to boosting shareholder value, apart from underlining confidence i ...
CION in 2026: M&A Pipeline, Tight Spreads and Private Credit Risk
ZACKS· 2026-03-02 18:06
Key Takeaways CION sees a stronger 2026 pipeline as lower rates and M&A recovery support originations and fees.Q3 income rose 32%, but tight spreads and intense private credit competition pressure returns.Non-accruals climbed since Q2 2025, making credit trends the key swing factor for 2026.CION Investment Corporation (CION) enters 2026 with two competing forces. A healthier origination backdrop could rebuild income momentum through new deployments and transaction fees. But tighter private credit terms and ...
Buy, Sell or Hold Broadcom Stock? Key Tips Ahead of Q1 Earnings
ZACKS· 2026-03-02 18:06
Key Takeaways Broadcom expects fiscal Q1 2026 revenues of $19.1B, up 29.2% year over year. AVGO's AI revenues are projected to double to $8.2B on strong XPU and switch demand. Broadcom flags AI mix pressure, softer non-AI chips and higher taxes as headwinds. Broadcom (AVGO) is set to report its first-quarter fiscal 2026 results on March 4.For first-quarter fiscal 2026, AVGO expects revenues of $19.1 billion. The Zacks Consensus Estimate for revenues is pegged at $19.27 billion, suggesting growth of 29.2% fr ...
GO's Q4 Earnings Coming Up: Will the Stock Extend Its Beat Streak?
ZACKS· 2026-03-02 18:06
Key Takeaways Grocery Outlet's off-price model and private-label push supported Q4 traffic.Grocery Outlet expanded its store refresh rollout to boost in-stock levels and ease of shop.Grocery Outlet faces margin pressure, with comps expected to rise just 0.4% in Q4.As Grocery Outlet Holdings Corporation (GO) prepares to unveil its fourth-quarter fiscal 2025 earnings on March 4, after market close. Investors are eager to see if the company can beat market expectations.The Zacks Consensus Estimate for revenues ...
CION Investment Trades at 5.5x and Yields a 15%: Hold or Buy?
ZACKS· 2026-03-02 18:06
Key Takeaways CION yields nearly 15% but has fallen 21.9% in six months, lagging industry's decline of 20.2%.CION trades at 5.5x forward EPS, below sub-industry, sector and S&P 500 averages.Non-accruals rose to 4.08% of portfolio, while NAV fell 5.5% year over year in Q3 2025.CION Investment Corporation (CION) is flashing the kind of yield that stops income investors mid-scroll. The dividend yield is higher, but the the stock has declined 21.9% over six months compared with the industry decline of 20.2%.Pri ...
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Reports Record Financial Performance
Financial Modeling Prep· 2026-03-02 18:06
Core Insights - Xeris Biopharma Holdings, Inc. has demonstrated significant growth with record financial performance for Q4 and the full year of 2025, and has provided optimistic financial guidance for 2026 [1] Financial Performance - On March 2, 2026, the company reported earnings per share of $0.06, surpassing the estimated $0.03, indicating strong performance against market expectations [2][5] - The revenue generated was $85.8 million, slightly below the estimated $86 million, yet the company's strategic focus remains evident [2][5] Valuation Metrics - The price-to-sales ratio stands at 3.48, indicating that investors are willing to pay $3.48 for every dollar of sales, reflecting positive market sentiment [3] - The enterprise value to sales ratio is 3.23, showing the company's total valuation compared to its revenue [3] - However, the enterprise value to operating cash flow ratio of 109.77 suggests that the company is generating less cash flow relative to its valuation, which may raise concerns for cash flow-focused investors [3] Financial Stability - The debt-to-equity ratio is 2.76, indicating that the company has more than twice as much debt as equity [4] - Despite the high debt levels, the current ratio of 2.19 suggests that Xeris Biopharma has a strong ability to cover its short-term liabilities with its short-term assets, providing a cushion for financial stability [4]
Operation Epic Fury: MLPX Becomes Strategic For A Hormuz-Closed World
Seeking Alpha· 2026-03-02 18:06
I don't know about my readers, but so far, 2026 has been a year so full of big events that it almost seems that a whole year has already gone by. And yet we are still in Q1. We allI’m a long-term investor focused on U.S. and European equities, with a dual emphasis on undervalued growth stocks and high-quality dividend growers. Through years of experience, I’ve learned that sustained profitability—evident in strong margins, stable and expanding free cash flow, and high returns on invested capital—is a more r ...